126 related articles for article (PubMed ID: 9366673)
1. Serum sulfotransferase levels in patients with macular corneal dystrophy type I.
Hassell JR; Klintworth GK
Arch Ophthalmol; 1997 Nov; 115(11):1419-21. PubMed ID: 9366673
[TBL] [Abstract][Full Text] [Related]
2. Measurement of activities of human serum sulfotransferases which transfer sulfate to the galactose residues of keratan sulfate and to the nonreducing end N-acetylglucosamine residues of N-acetyllactosamine trisaccharide: comparison between normal controls and patients with macular corneal dystrophy.
Hasegawa N; Torii T; Nagaoka I; Nakayasu K; Miyajima H; Habuchi O
J Biochem; 1999 Feb; 125(2):245-52. PubMed ID: 9990120
[TBL] [Abstract][Full Text] [Related]
3. Human corneal GlcNac 6-O-sulfotransferase and mouse intestinal GlcNac 6-O-sulfotransferase both produce keratan sulfate.
Akama TO; Nakayama J; Nishida K; Hiraoka N; Suzuki M; McAuliffe J; Hindsgaul O; Fukuda M; Fukuda MN
J Biol Chem; 2001 May; 276(19):16271-8. PubMed ID: 11278593
[TBL] [Abstract][Full Text] [Related]
4. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy.
Hasegawa N; Torii T; Kato T; Miyajima H; Furuhata A; Nakayasu K; Kanai A; Habuchi O
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3670-7. PubMed ID: 11053262
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel mutations in the carbohydrate sulfotransferase gene (CHST6) causing macular corneal dystrophy.
El-Ashry MF; Abd El-Aziz MM; Wilkins S; Cheetham ME; Wilkie SE; Hardcastle AJ; Halford S; Bayoumi AY; Ficker LA; Tuft S; Bhattacharya SS; Ebenezer ND
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):377-82. PubMed ID: 11818380
[TBL] [Abstract][Full Text] [Related]
6. Macular corneal dystrophy. Lack of keratan sulfate in serum and cornea.
Klintworth GK; Meyer R; Dennis R; Hewitt AT; Stock EL; Lenz ME; Hassell JR; Stark WJ; Kuettner KE; Thonar EJ
Ophthalmic Paediatr Genet; 1986 Dec; 7(3):139-43. PubMed ID: 2951638
[TBL] [Abstract][Full Text] [Related]
7. Absence of normal keratan sulfate in the blood of patients with macular corneal dystrophy.
Thonar EJ; Meyer RF; Dennis RF; Lenz ME; Maldonado B; Hassell JR; Hewitt AT; Stark WJ; Stock EL; Kuettner KE
Am J Ophthalmol; 1986 Nov; 102(5):561-9. PubMed ID: 2946233
[TBL] [Abstract][Full Text] [Related]
8. Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures.
Klintworth GK; Smith CF
Am J Pathol; 1977 Oct; 89(1):167-82. PubMed ID: 143892
[TBL] [Abstract][Full Text] [Related]
9. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin/dermatan sulfate in macular corneal dystrophy.
Plaas AH; West LA; Thonar EJ; Karcioglu ZA; Smith CJ; Klintworth GK; Hascall VC
J Biol Chem; 2001 Oct; 276(43):39788-96. PubMed ID: 11514545
[TBL] [Abstract][Full Text] [Related]
10. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype.
Klintworth GK; Oshima E; al-Rajhi A; al-Saif A; Thonar EJ; Karcioglu ZA
Am J Ophthalmol; 1997 Jul; 124(1):9-18. PubMed ID: 9222226
[TBL] [Abstract][Full Text] [Related]
11. Truncating mutations in the carbohydrate sulfotransferase 6 gene (CHST6) result in macular corneal dystrophy.
Niel F; Ellies P; Dighiero P; Soria J; Sabbagh C; San C; Renard G; Delpech M; Valleix S
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2949-53. PubMed ID: 12824236
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the CHST6 gene in patients with macular corneal dystrophy: immunohistochemical evidence of heterogeneity.
Iida-Hasegawa N; Furuhata A; Hayatsu H; Murakami A; Fujiki K; Nakayasu K; Kanai A
Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3272-7. PubMed ID: 12882769
[TBL] [Abstract][Full Text] [Related]
13. Partial purification and characterization of 3'-phosphoadenylylsulfate:keratan sulfate sulfotransferases.
Rüter ER; Kresse H
J Biol Chem; 1984 Oct; 259(19):11771-6. PubMed ID: 6592165
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in American patients with macular corneal dystrophy.
Aldave AJ; Yellore VS; Thonar EJ; Udar N; Warren JF; Yoon MK; Cohen EJ; Rapuano CJ; Laibson PR; Margolis TP; Small K
Am J Ophthalmol; 2004 Mar; 137(3):465-73. PubMed ID: 15013869
[TBL] [Abstract][Full Text] [Related]
15. Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan.
Hassell JR; Newsome DA; Krachmer JH; Rodrigues MM
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3705-9. PubMed ID: 6447876
[TBL] [Abstract][Full Text] [Related]
16. [Immunophenotype classification of macular corneal dystrophy: first case report of immunophenotype I A outside of Saudi Arabia. A clinical histopathological correlation with immunohistochemistry and electron microscopy].
Cursiefen C; Hofmann-Rummelt C; Schlötzer-Schrehardt U; Fischer DC; Küchle M
Klin Monbl Augenheilkd; 2000 Aug; 217(2):118-26. PubMed ID: 11022667
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in macular corneal dystrophy.
Edward DP; Yue BY; Sugar J; Thonar EJ; SunderRaj N; Stock EL; Tso MO
Arch Ophthalmol; 1988 Nov; 106(11):1579-83. PubMed ID: 3056354
[TBL] [Abstract][Full Text] [Related]
18. Abnormal product of corneal explants from patients with macular corneal dystrophy.
Klintworth GK; Smith CF
Am J Pathol; 1980 Oct; 101(1):143-58. PubMed ID: 6969547
[TBL] [Abstract][Full Text] [Related]
19. Macular corneal dystrophy: A review.
Aggarwal S; Peck T; Golen J; Karcioglu ZA
Surv Ophthalmol; 2018; 63(5):609-617. PubMed ID: 29604391
[TBL] [Abstract][Full Text] [Related]
20. [Keratan sulfate biosynthesis and macular corneal dystrophy].
Akama TO; Fukuda MN; Nakayama J
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1147-51. PubMed ID: 12807022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
